University Medical Associates of the Medical University of South Carol
University Medical Associates of the Medical University of South Carol was paid $2.80M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
CHARLESTON, SC 29425
Next to other Cardiovascular Disease Physician providers in South Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,205 | $552K | |
| 2019 | 24,171 | $510K | |
| 2020 | 19,947 | $429K | |
| 2021 | 20,294 | $448K | |
| 2022 | 19,791 | $373K | |
| 2023 | 15,410 | $266K | |
| 2024incomplete | 12,763 | $219K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 21,590 | 20,466 | $671K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 16% | 11,597 | 11,317 | $445K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 14% | 3,858 | 1,570 | $391K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 9.0% | 63,019 | 56,040 | $252K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.5% | 5,624 | 5,191 | $210K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.5% | 4,228 | 1,984 | $125K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.9% | 2,184 | 1,736 | $108K |
| 36512 | 2.9% | 1,666 | 1,596 | $82K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 2.8% | 4,460 | 4,386 | $79K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.5% | 1,534 | 630 | $69K |
| 99205 | Prolong outpt/office vis | 2.4% | 526 | 518 | $67K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.2% | 1,449 | 1,390 | $33K |
47 more codes
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.2% | 438 | $33K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1.1% | 15 | $32K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 374 | $31K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 958 | $23K |
| 94010 | <1% | 5,173 | $21K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 1,215 | $18K |
| 90961 | <1% | 752 | $18K | |
| 94729 | <1% | 2,529 | $9K | |
| 93750 | <1% | 651 | $8K | |
| 99254 | <1% | 67 | $8K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 585 | $7K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 112 | $6K |
| 95782 | <1% | 68 | $6K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 17 | $5K |
| 93295 | <1% | 269 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 99 | $4K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 31 | $3K |
| 93308 | <1% | 243 | $3K | |
| 93356 | <1% | 114 | $3K | |
| 99255 | <1% | 16 | $2K | |
| 94618 | <1% | 232 | $2K | |
| 93000 | <1% | 260 | $2K | |
| 43762 | <1% | 160 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 88 | $1K |
| 99223 | Prolong inpt eval add15 m | <1% | 47 | $1K |
| 94726 | <1% | 233 | $1K | |
| 96415 | <1% | 118 | $1K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $983.36 |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 24 | $955.92 |
| 93325 | <1% | 406 | $794.41 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 43 | $707.07 |
| 99442 | <1% | 42 | $660.86 | |
| 95811 | <1% | 13 | $594.71 | |
| 93296 | <1% | 64 | $568.74 | |
| 93294 | <1% | 47 | $544.12 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $443.09 |
| 93321 | <1% | 136 | $367.09 | |
| 93297 | <1% | 77 | $343.29 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 61 | $331.29 |
| 93298 | <1% | 25 | $260.56 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 38 | $250.92 |
| 94060 | <1% | 28 | $177.32 | |
| 93320 | <1% | 12 | $154.38 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 103 | $146.00 |
| 99152 | <1% | 16 | $63.65 | |
| 99441 | <1% | 14 | $25.26 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 808 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.